PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $71,000 | -16.5% | 11,376 | +7.7% | 0.00% | -33.3% |
| Q2 2018 | $85,000 | +7.6% | 10,560 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $79,000 | +64.6% | 10,560 | +30.7% | 0.00% | +50.0% |
| Q4 2017 | $48,000 | +9.1% | 8,080 | +34.0% | 0.00% | 0.0% |
| Q3 2017 | $44,000 | +41.9% | 6,032 | +31.8% | 0.00% | +100.0% |
| Q2 2017 | $31,000 | +55.0% | 4,576 | +115.0% | 0.00% | 0.0% |
| Q1 2017 | $20,000 | – | 2,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |